SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Pennsylvania Could Legalize Adult-Use Cannabis to Tackle Budget Crisis

    By

    A budget crisis could make Pennsylvania the next state to legalize adult-use cannabis. Pennsylvania lawmakers are staring down a gap as big as $3.7 billion, and they have few options to fill it other than revenue from regulated and taxed cannabis.

    Gov. Josh Shapiro, a likely contender for the 2028 Democratic presidential nomination, has pledged that he will once again use his annual budget address on Feb. 4 to call on state lawmakers to legalize adult use in Pennsylvania.

    The cannabis industry, in turn, organized a fundraiser for the governor in early January, and some of the state’s medical cannabis operators took the opportunity to inform Shapiro that up to 60% of customers shopping at adult-use stores in Maryland, New Jersey and Ohio come from Pennsylvania, several attendees told MJBizDaily.

    That represents lost revenue for Pennsylvania cannabis businesses, which underscores a key issue for Shapiro – the state’s budget deficit. Lawmakers, operators and advocates alike believe that budget pressure will be what finally gets longstanding bipartisan recreational cannabis legislation across the line in 2025.

    This article was originally published on MJBizDaily, you can read the full article here. 

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    MJBizDaily

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free